Clinical Trial Update: DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma [Phase 2]

View source ↗

Summary

This Phase II trial investigates first-line therapy with enfortumab vedotin plus avelumab for advanced penile squamous cell carcinoma; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)
• Padcev (enfortumab vedotin)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Penile Squamous Cell Carcinoma (PSCC) | Phase 2 | Status: RECRUITING